Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Prog Retin Eye Res. 2021 Jan 8;84:100940. doi: 10.1016/j.preteyeres.2021.100940

Figure 10. Measurement of complement activation products C3a, C4a and C5a in human serum samples.

Figure 10.

Levels of C3a (A) and C5a (B), but not C4a (C) were significantly higher in the DR group compared to age-matched healthy controls. Data were mean ± SD. Each dot represents one patient (Adapted from Lingjun Zhang et al., 2016).